Federated Hermes’s Akcea Therapeutics Inc AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,829
Closed -$33K 2421
2020
Q3
$33K Buy
1,829
+584
+47% +$8.29K ﹤0.01% 1838
2020
Q2
$17K Sell
1,245
-24,993
-95% -$386K ﹤0.01% 1893
2020
Q1
$375K Buy
+26,238
New +$431K ﹤0.01% 1457

Federated Hermes's AKCA Position: Q4 2020 in Review

Federated Hermes sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 1,829 shares — an estimated $33K sold.

Federated Hermes first reported a position in AKCA in Q1 2020 and held it in 3 quarters. The position peaked at $375K in Q1 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Federated Hermes reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Federated Hermes sold 1,829 Akcea Therapeutics Inc shares in Q4 2020, an estimated $33K.
  • Federated Hermes first reported a position in Akcea Therapeutics Inc in Q1 2020 and held it in 3 quarters.
  • Federated Hermes's Akcea Therapeutics Inc position peaked at $375K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Federated Hermes's 13F filing for Q4 2020, filed 12 Feb 2021.